World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
115
Citations
91804
World Ranking
387
National Ranking
15

Molecular Biology

D-Index
110
Citations
83943
World Ranking
364
National Ranking
12

Medicine

D-Index
115
Citations
91788
World Ranking
4422
National Ranking
165

Ton N. M. Schumacher publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Ton N. M. Schumacher sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 358 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Ton N. M. Schumacher D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Ton N. M. Schumacher sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 110 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2017 - Member of Academia Europaea
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Ton N. M. Schumacher is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a significant focus on Oncology and Immunology as subfields. The scientific work conducted by Schumacher involves several topics, including cancer immunotherapy and biomarkers, immunotherapy and immune responses, CAR-T cell therapy research, immune cell function and interaction, T-cell and B-cell immunology, immune cells in cancer, and vaccines and immunoinformatics approaches.

Schumacher's recent publications include:

  • "B cells and tertiary lymphoid structures promote immunotherapy response," 2020, Nature
  • "CD8+ T cell states in human cancer: insights from single-cell analysis," 2020, Nature reviews. Cancer
  • "Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers," 2020, Nature Medicine
  • "Tertiary lymphoid structures in cancer," 2022, Science
  • "The CD47-SIRPα Immune Checkpoint," 2020, Immunity

The venues where Schumacher frequently publishes their work include bioRxiv (Cold Spring Harbor Laboratory), Annals of Oncology, Nature Medicine, Cancer Research, and Regular and Young Investigator Award Abstracts.

Among frequent co-authors associated with Schumacher are:

  • John B.A.G. Haanen
  • Christian U. Blank
  • Mireille Toebes
  • Daniela S. Thommen
  • Pia Kvistborg

Schumacher's contributions have been recognized through membership in the Academia Europaea, awarded in 2017.

Best Publications

  • Signatures of mutational processes in human cancer

    Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio

  • Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

    Naiyer A. Rizvi;Naiyer A. Rizvi;Matthew D. Hellmann;Matthew D. Hellmann;Alexandra Snyder;Alexandra Snyder;Pia Kvistborg

  • Neoantigens in cancer immunotherapy

    Ton N. Schumacher;Robert D. Schreiber

  • Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

    Jesse M. Zaretsky;Angel Garcia-Diaz;Daniel S. Shin;Helena Escuin-Ordinas

  • B cells and tertiary lymphoid structures promote immunotherapy response

    Beth A. Helmink;Sangeetha M. Reddy;Jianjun Gao;Shaojun Zhang

  • Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

    Matthew M. Gubin;Xiuli Zhang;Heiko Schuster;Etienne Caron

  • Regulation and Function of the PD-L1 Checkpoint

    Chong Sun;Riccardo Mezzadra;Ton N. Schumacher

  • The Human Cell Atlas

    Aviv Regev;Aviv Regev;Aviv Regev;Sarah A Teichmann;Sarah A Teichmann;Sarah A Teichmann;Eric S Lander;Eric S Lander;Eric S Lander;Ido Amit

  • Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.

    R. P.M. Sutmuller;L. M. Van Duivenvoorde;A. Van Elsas;T. N.M. Schumacher

  • Defining ‘T cell exhaustion’

    Christian U Blank;W Nicholas Haining;Werner Held;Patrick G Hogan;Patrick G Hogan

  • CD8+ T cell states in human cancer: insights from single-cell analysis

    Anne M. van der Leun;Daniela S. Thommen;Ton N. Schumacher

  • Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.

    Myriam Chalabi;Lorenzo F Fanchi;Krijn K Dijkstra;José G Van den Berg

  • T Cell Dysfunction in Cancer.

    Daniela S. Thommen;Ton N. Schumacher

  • Empty MHC class I molecules come out in the cold

    H G Ljunggren;N J Stam;C Ohlén;J J Neefjes

  • A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade

    Daniela S. Thommen;Daniela S. Thommen;Viktor H. Koelzer;Petra Herzig;Andreas Roller

  • Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma

    Hanjie Li;Anne M. van der Leun;Ido Yofe;Yaniv Lubling

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis

  • Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

    Krijn K Dijkstra;Chiara M Cattaneo;Fleur Weeber;Myriam Chalabi

  • CD27 is required for generation and long-term maintenance of T cell immunity

    J Hendriks;L A Gravestein;K Tesselaar;R A van Lier

  • Tertiary lymphoid structures in cancer

    Unknown

  • Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma

    Nienke van Rooij;Marit M. van Buuren;Daisy Philips;Arno Velds

Frequent Co-Authors

John B. A. G. Haanen
John B. A. G. Haanen Antoni van Leeuwenhoek Hospital
Christian U. Blank
Christian U. Blank Antoni van Leeuwenhoek Hospital
Sine Reker Hadrup
Sine Reker Hadrup Technical University of Denmark
Hidde L. Ploegh
Hidde L. Ploegh Boston Children's Hospital
Annegien Broeks
Annegien Broeks Antoni van Leeuwenhoek Hospital
Lodewyk F. A. Wessels
Lodewyk F. A. Wessels Antoni van Leeuwenhoek Hospital
Nir Hacohen
Nir Hacohen Harvard University
Hergen Spits
Hergen Spits University of Amsterdam
Michael R. Stratton
Michael R. Stratton Wellcome Sanger Institute
Daniel S. Peeper
Daniel S. Peeper Antoni van Leeuwenhoek Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing a career in healthcare often intersects with nursing and advanced practice roles. Many students explore online accelerated nursing programs for non nurses as a fast track into nursing, especially if they hold a degree in a related science field. These programs provide foundational nursing skills, enabling graduates to work closely with immunologists in clinical settings.

If admission competitiveness is a concern, options like the easiest accelerated nursing programs to get into offer flexible pathways without compromising educational quality. These programs can help jumpstart a healthcare career supporting immunological research or patient care.

For those starting their nursing journey, exploring the best easiest LPN programs to get into is a practical option. Licensed Practical Nurses often support immunology patients in hospitals or clinics, providing essential care under supervision.

Lastly, individuals aiming for advanced clinical roles may consider easiest online nurse practitioner programs. These allow flexible learning while gaining expertise to diagnose and manage immunological disorders, expanding career opportunities in this specialized field.

Best Scientists Citing Ton N. M. Schumacher

Trending Scientists

Recently Published Articles